Unraveling the Physiology of (pro)renin Receptor in the Distal Nephron
Tianxin Yang
DOI: https://doi.org/10.1161/hypertensionaha.116.08318
IF: 9.8968
2017-01-01
Hypertension
Abstract:HomeHypertensionVol. 69, No. 4Unraveling the Physiology of (Pro)Renin Receptor in the Distal Nephron Free AccessReview ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessReview ArticlePDF/EPUBUnraveling the Physiology of (Pro)Renin Receptor in the Distal Nephron Tianxin Yang Tianxin YangTianxin Yang From the Department of Internal Medicine, University of Utah and Veterans Affairs Medical Center, Salt Lake City; and Institute of Hypertension, Sun Yat-sen University School of Medicine, Guangzhou, China. Search for more papers by this author Originally published27 Feb 2017https://doi.org/10.1161/HYPERTENSIONAHA.116.08318Hypertension. 2017;69:564–574Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: January 1, 2017: Previous Version 1 The classic renin–angiotensin system (RAS) is a well-defined endocrine system consisting of liver production of angiotensinogen, which is converted to angiotensin I by renin followed by a second cleavage to angiotensin II (AngII) by angiotensin-converting enzyme located on the surface of lung endothelium.1,2 AngII is the major effector hormone of the RAS, playing a key role in the maintenance of extracellular volume, blood pressure, renal hemodynamics, and tubular sodium transport, as well as in the pathogenesis of cardiovascular and renal diseases.3–5 AngII acts on 2 types of membrane receptors, AngII type 1 receptor and type 2 receptor. The RAS interventions targeting AngII type 1 receptor and angiotensin-converting enzyme are widely used for management of hypertension, renal disease, and cardiovascular disease. During the past several decades, the RAS has evolved into a highly complex system as highlighted by the discovery of angiotensin-converting enzyme 2/Ang 1 to 7/Mas pathway and the local RAS found in several tissues, such as the kidney, the heart, and the brain.1,6,7 The RAS activity is largely controlled by renin-mediated conversion of angiotensinogen to Ang I, a rate-limiting step in the RAS. Renin is a protease produced by juxtaglomerular cells of the afferent arteriole as well as collecting duct (CD) principal cells,8 mast cells,9 adipocytes,10 etc. Prorenin, a precursor of renin, contains a prosegment covering the catalytic domain and undergoes proteolytic cleavage to generate the mature renin. Plasma prorenin levels are elevated in diabetic patients and predict microvascular complications, whereas plasma renin is normal or low.11 Animal data suggests that excess prorenin compared with active renin in diabetes mellitus originates from the CD rather than from the juxtaglomerular apparatus.12 High prorenin state is also seen in normal pregnancy.13,14In 2002, Nguyen et al15 cloned a novel receptor for prorenin and renin, termed (pro)renin receptor (PRR), and assigned a renin-regulatory function to this receptor. Renin bound to PRR exhibits a 3- to 5-fold increased renin activity.15 Furthermore, when PRR binds prorenin, the later undergoes conformational changes to unfold the inhibitory prosegment of prorenin, leading to nonproteolytic activation.15 A soluble form of PRR (sPRR) is generated by intracellular cleavage by furin and secreted in plasma.16 On the basis of the structure, PRR belongs to type I transmembrane receptor family, consisting of a large N-terminal extracellular domain, a single transmembrane protein, and a short cytoplasmic domain.15,17 Amino acid sequence analysis reveals that the intracellular domain of PRR is highly conserved among all species, whereas the extracellular domain shares high homology only in mammals. The conservation scores (identity /AA) are 6.8 for the intracellular domain (M8.9) and 3.8 for the extracellular domain (sPRR) among all species, and 8.7 for the intracellular domain and 8.9 for sPRR in mammals (Figure 1). This result is compatible with the concept that sPRR may serve an important function in mammals, whereas M8.9 may participate in fundamental survival functions across all species.Download figureDownload PowerPointFigure 1. Distinct conservations of different domains of (pro)renin receptor (PRR). The protein sequence alignment was generated by the Clustal X 2.0 multiple sequence alignment program using default parameters. The PRR protein sequences were from GenBank accession numbers NP_005756.2 (human), NP_001126837.1 (Pongo abelii), AAH79339.1 (rat), NP_081715.1 (mouse), NP_001080880.1 (Xenopuslaevis), NP_998188.2 (Zebrafish), NP_510360.1 (Caenorhabditis elegans), and NP_649876.1 (Drosophila melanogaster). A, Alignment of amino acid sequence of PRR. The score depicts conservation between different species. The scores on the bottom 2 rows depict degrees of conservation across all species and the mammals only. The transmembrane domain (TM), the intracellular domain (ICD), and furin-mediated cleavage site are highlighted. B, The summary of the conservation scores.Within the kidney, PRR is expressed in multiple cell types and is most abundantly detected in the intercalated cells of the CD,18–20 a site for fine-tuning urinary excretion of water and electrolytes; the expression of PRR in the CD is stimulated by chronic AngII infusion21 or Na+ depletion.22,23 During the past decade, understanding the physiological function of PRR has been hindered by the lethal phenotype of complete or conditional deletion of PRR and also the lack of an effective PRR inhibitor with the controversial antagonistic effect of handle region peptide on the PRR.24–26 In recent years, the availability of various strains of viable renal PRR knockout (KO) models along with the newly developed PRR decoy inhibitor PRO20 has greatly facilitated the process in unraveling the physiological function of renal PRR. The existing in vivo data suggests that PRO20 acts via inhibition of the RAS during both AngII infusion and deoxycorticosterone acetate–salt hypertension,27,28 although in vitro data shows the RAS-independent effect of this inhibitor on epithelial Na+ channel (ENaC) activity.29 The goal of this review is to highlight recent advances in identifying the roles of PRR in the nephron, particularly in the CD, for regulation of Na+ and water balance and blood pressure.PRR Regulation of Na+ HomeostasisA series of recent studies from our group and others have identified the prorenin/PRR pathway as a potential regulator of ENaC in the CD. Because prorenin/renin and PRR are coexpressed in the CD, we hypothesized that their interactions in an autocrine or paracrine fashion may affect ENaC activity. To address this possibility, we performed electrophysiological studies using mpkCCD cell line grown on Transwells. Using this system, we made an initial observation that prorenin treatment in the nanomolar range induced a rapid and transient increase in ENaC-mediated Na+ transport (Figure 2) through Nox4-derived H2O2.29 Interestingly, renin treatment was largely ineffective. In agreement of this observation, multiple studies suggest that prorenin has higher affinity to PRR than renin.30,31 The dependence of the Na+ stimulatory effect of prorenin on PRR was validated by using a PRR decoy inhibitor PRO20.29 This effect was independent of canonical RAS because AT1 receptor inhibition with losartan was ineffective (Figure 2). These results suggest that prorenin via PRR induces Nox4-derived reactive oxygen species, resulting in a direct activation of ENaC. In agreement with this finding, Ramkumar et al32 observed a similar stimulatory effect of prorenin on ENaC activity in isolated split-open CD. Moreover, the prorenin effect was similarly unaffected by AT1 blockade.32 Besides the ENaC regulation at activity level, PRR also upregulates α-ENaC mRNA expression in mIMCD3 cells exposed to low-salt media or AngII through serine/threonine-protein kinase-1 and phosphorylated Nedd4-2 (also known as Nedd4L [neural precursor cell-expressed developmentally downregulated gene 4-like]).33 Together, the in vitro results suggest that PRR can modulate ENaC expression and activity through distinct mechanisms.Download figureDownload PowerPointFigure 2. Effect of prorenin/(pro)renin receptor (PRR) on epithelial Na+ channel (ENaC) activity in cultured collecting duct (CD) cells. Confluent mpkCCD cells grown on Transwells were pretreated for 30 min with PRO20 (1.5 µmol/L) or losartan (Los; 1.0 µmol/L) and then treated with prorenin (10 nmol/L). Ieq was monitored for a 15-min period by using an epithelial volt-ohmmeter. In a separate experiment, the time point of peak stimulation of Na+ transport at 1 min was chosen for measuring amiloride-sensitive Ieq, an index of ENaC activity. A, Time course of Ieq changes in control, prorenin, and prorenin+PRO20 groups. B, Corresponding amiloride-sensitive Ieq for experiments in (A). C, Time course of Ieq changes in control, prorenin, and prorenin+losartan groups. D, Corresponding amiloride-sensitive Ieq for experiments in (C). *P<0.05 vs basal in the same group; #P<0.05 vs prorenin. n=6 to 12 per group. Data are means±SE. Adapted from Lu et al.29 Copyright © 2016, American Physiological Society.Besides the above-mentioned in vitro data, strong in vivo data from 3 independent studies all support an important role of PRR in ENaC regulation under basal and pathophysiological conditions.29,32,33 To our surprise, PRR regulation of ENaC seems to occur only in the renal medulla but not in the cortex. In this regard, we found that the renal inner medullary α-ENaC under basal condition or after AngII infusion was reduced in CD PRR KO mice.34 In contrast, renal cortical α-ENaC expression was unaffected by AngII or CD PRR KO. Moreover, the other ENaC subunits (β and γ) remain unchanged. In agreement with our results, Quadri et al33 showed that in vivo delivery of shRNA against PRR to the kidney of Sprague-Dawley rats selectively reduced α-ENaC expression in the renal medulla but not in the cortex despite the gene knockdown in the whole kidney. These results suggest that PRR may primarily target renal medullary (or inner medullary) ENaC to regulate Na+ balance and BP.As compared with the overwhelming information about Na+ transport process in the early part of the CD,35–38 little attention has been paid to the terminal part of the CD, for example, the inner medullary collecting duct (IMCD). Part of the reason is that the IMCD in rabbits or rats is highly branched or difficult to dissect because of tightly adherent tissues and therefore is not easily accessible to microperfusion as for the cortical CD. The literature concerning net Na+ transport in the IMCD is controversial. It has been difficult to demonstrate net Na+ reabsorption in isolated perfused IMCD by measurement of Na+ concentrations in the perfusate.39 However, other studies reported robust Na+ reabsorption in this nephron segment.40,41 Furthermore, the apical membrane conductance in the IMCD because of passive movement of Na+ is detected and attributed to amiloride-sensitive conductive pathway.42 In addition, Na+ reabsorption in the IMCD has been demonstrated by using micropuncture techniques. The IMCD is accessible to micropuncture through a retrograde placement of thin pipettes from the tip of the IMCD. Early micropuncture studies using this technique have demonstrated active net Na+ reabsorption in the IMCD.43,44 More importantly, Na+ reabsorption in the IMCD fluctuates in response to altered plasma volume so that it is increased during hypovolemia but suppressed during volume expansion44–47 despite a conflicting report.48 Overall, these results suggest a potential role of Na+ transport in the IMCD in the control of Na+ excretion during alteration of plasma volume. Unfortunately, this area has almost remained uninvestigated during the past decade. It is anticipated that the demonstration of PRR as a regulator of renal medullary ENaC will provide an impetus for re-evaluation of importance of Na+ transport in the IMCD.As discussed above, PRR regulation of renal medullary α-ENaC contributes to pathogenesis of AngII-induced hypertension.34 In addition, dysregulation of renal medullary ENaC has been implicated in the development of salt-sensitive hypertension in Dahl salt–sensitive rats.49 Based on the conductive permeability to Na+ and the rate of Na+ transport, the IMCD cells from Dahl salt-sensitive rats transport twice as much Na+ as the cells from Dahl salt–resistant rats.50,51 Consistent with this finding, the mRNA of β- and γ-ENaC and the protein abundance of all 3 ENaC subunits are increased in the renal medulla of Dahl salt-sensitive rats under basal condition and after high salt intake as compared with Dahl salt-resistant rats.49 Additionally, aberrant activation of intrarenal RAS has been suggested to play a role in the Dahl salt-sensitive model, which is traditionally considered as a low renin hypertension model. Despite the similar suppression of plasma angiotensinogen in both strains, high salt enhances renal and urinary levels of angiotensinogen in Dahl salt-sensitive but not in Dahl salt-resistant rats.52 Future studies need to address the precise location of the intrarenal RAS activation and possible involvement of PRR in salt-sensitive hypertension in the Dahl salt-sensitive model.PRR Regulation of Water HomeostasisMost mammals can produce highly concentrated urine when water consumption is reduced so that a constant plasma osmolality can be maintained. Such urine-concentrating capability resides in the renal medulla and is chiefly determined by arginine vasopressin (AVP).53,54 The antidiuretic action of AVP is mediated by enhancement of water permeability of the CD and the generation of osmotic gradient because of increased NaCl reabsorption in the thick acceding limb (TAL).54,55 In the CD, AVP via arginine vasopressin receptor 2 (V2R) activates cyclic AMP/protein kinase A pathway that induces aquaporin-2 (AQP2) trafficking to the apical membrane and expression leading to increased water permeability.53 We discovered that AVP-stimulated AQP2 expression depends on prorenin activation of PRR.56 In primary rat IMCD cells on Transwells, AVP induced a marked increase in AQP2 protein expression. To address the involvement of PRR, we used 3 independent approaches to inhibit PRR: a pharmacological inhibitor, a small and interfering RNA, and a neutralizing PRR antibody. Inhibition of PRR with either one of these approaches was highly effective to suppress AQP2 upregulation by AVP. Furthermore, activation of PRR with prorenin but not renin induced a marked increase in AQP2 expression (Figure 3). AVP also stimulated release of prorenin and sPRR in primary rat IMCD cells.56 In M-1 CD cell line, a similar enhancement of renin mRNA, prorenin, and renin is observed after desmopressin (ddAVP) treatment.57 Together, the in vitro data demonstrates a potential role of PRR in mediating AVP-induced AQP2 expression in the CD cells. However, whether PRR regulates AVP-induced AQP2 trafficking remains uninvestigated.Download figureDownload PowerPointFigure 3. The direct role of prorenin/(pro)renin receptor (PRR) in regulation of aquaporin-2 (AQP2) expression in the collecting duct (CD) cells. Primary rat inner medullary collecting duct cells were pretreated with PRO20 or anti-PRR-N antibody or pretransfected with PRR small and interfering RNA (siRNA) and then treated for 24 h with 10 nmol/L prorenin. AQP2 protein expression was determined by immunoblotting and normalized by β-actin. A, Effect of prorenin alone or in combination with PRO20 on AQP2 expression (n=6 per group). B, Effect of prorenin alone or in combination with anti-PRR-N antibody on AQP2 expression (n=6 per group). C, Effect of prorenin alone or in combination with PRR knockdown on AQP2 expression (n=6 per group). Adapted from Wang et al56 with permission of the publisher. Copyright © 2016, American Society of Nephrology. Authorization for this adaptation has been obtained both from the owner of the copyright in the original work and from the owner of copyright in the translation or adaptation.In agreement with the in vitro data as discussed above, compelling in vivo data are also available to support antidiuretic action of renal PRR. First, renal full-length PRR protein abundance is consistently elevated in rats after 48-hour or 72-hour water deprivation (WD).56,58 Interestingly, this maneuver increases urinary sPRR excretion56 but decreases plasma sPRR.55 This result may suggest differences in the origin of urinary and plasma sPRR. Second, pharmacological inhibition of intrarenal PRR results in impaired urine-concentrating capability.56 In this regard, PRO20 is administered via an infusion catheter chronically implanted in the kidney of nephrectomized rats followed by 48-hour WD. Intrarenal PRO20 infusion partially attenuates the reduction of urine volume and the increase of urine osmolality and the expression of AQP2 in the WD rats. Finally, conditional deletion of PRR56 in the CD and the whole nephron59,60 causes a common polyuria phenotype. CD PRR KO mice generated by using AQP2-Cre are not associated with renal developmental abnormality seen in the null model produced by using Hoxb7-Cre.61 The whole nephron PRR deletion is generated by using an inducible way wherein PRR ablation occurs in adulthood so that the developmental stage is bypassed. All of these KO models have increased urine volume and decreased urine osmolality under basal condition and exhibit impaired ability to concentrate urine after WD. Evidence is available to suggest impairment of AVP signaling in these models. For example, renal AQP2 expression is consistently downregulated in these models, and AVP sensitivity is also blunted in the nephron PRR KO mice. Besides AQP2, renal expression of Na/K/2Cl cotransporter, another target of AVP in the TAL,55 is also suppressed in the null mice. These results suggest that PRR is indispensable for AVP signaling in both the CD and the TAL. However, it is important to note that interpretation of the phenotype of the nephron PRR KO model is complicated by renal structural abnormalities because of accumulation of autophagosome particularly in the TAL. This result raises a possibility that the downregulation of transporter proteins such as Na/K/2Cl cotransporter in this model may be secondary to an autophagic defect in the renal epithelial cells.EP4 Regulation of PRRFurther evidence suggests that prostaglandin EP4 receptors are required for enhancement of PRR and hence AQP2 after AVP treatment. PGE2 is one of the major cyclooxygenase-derived metabolites of arachidonic acid produced in the kidney, particularly the IMCD.62,63 PGE2 acts on 4 distinct G protein–coupled receptors, designated EP1–4, to induce a wide spectrum of biological functions.64 PGE2 exerts a prominent, yet complex, role in the regulation of water homeostasis through distinct EP receptors. In particular, PGE2 and sulprostone, an EP1/3 agonist, blunt AVP-induced AQP2 trafficking and urine concentration,65–68 whereas EP2 and EP4 agonists induces AQP2 trafficking to the apical membrane and alleviate the symptoms of nephrogenic diabetes insipidus (NDI) in rodents.69 A nonbiased gene expression analysis of G protein–coupled receptor in mouse IMCD cells identified the prostaglandin EP4 subtype as the highly expressed G protein–coupled receptor in addition to the V2R.69 In microdissected nephron segments, EP4 mRNA was abundantly detected in the cortical CD,70 where PGE2 stimulated cyclic AMP production.71 After 24-hour WD, EP4 protein expression is remarkably upregulated contrasting to unchanged expression of the other 3 EP subtypes,72 indicating a unique role of EP4 receptors in regulation of water homeostasis. This notion has been confirmed by generation of nephron-specific (Ksp-EP4−/−) and CD-specific (AQP2-EP4−/−) deletion of EP4, both of which impair urine-concentrating capability.72 An earlier study from our group showed that EP4 acting downstream of cyclooxygenase-2 mediates upregulation of renal medullary PRR and the intrarenal RAS during AngII-induced hypertension.73,74 Therefore, we proposed a hypothesis that PGE2/EP4 pathway may mediate the antidiuretic action of AVP via targeting PRR and the intrarenal RAS. We found that in primary rat IMCD cells, activation of EP4 receptors was able to stimulate AQP2 expression, and conversely, inhibition of this receptor subtype effectively attenuates AVP-induced AQP2 expression.56 These results suggest the EP4 receptor as a mediator of AVP-induced AQP2 expression. Because EP4 agonist stimulated PRR expression74 and EP4-induced AQP2 expression was blunted by inhibition of PRR, the EP4 receptor should act downstream of AVP and upstream of PRR in regulation of AQP2 expression.Biological Function of sPRRPRR contains a protease cleavage site at the N-terminal domain near the transmembrane domain.15 sPRR was originally shown to be generated by intracellular cleavage by furin and detected in the conditioned medium of cultured cells.16 This conclusion was based on the observations that LoVo colon carcinoma cells deficient in furin did not produce sPRR despite the expression of full-length PRR and that overexpression of α1-antitrypsin Portland variant, an inhibitor of furin, completely suppressed sPRR production in Chinese hamster ovary cells.16 However, the role of furin as the cleaving enzyme was not confirmed by another study.75 In the later study, ADAM19, but not furin, is shown to be responsible for the cleavage process.75 Moreover, in cultured vascular smooth muscle cells, PRR is mainly localized to the endoplasmic reticulum and the Golgi and shed by ADAM19 in the Golgi, leading to the secretion of sPRR to the extracellular space where it enhances renin activity of prorenin.75 Thus, the relative importance of furin versus ADAM19 in this cleavage event remains elusive.A large number of clinical studies suggest importance of circulating sPRR. sPRR can be measured by ELISA,76 which offers a simple tool for assessment of sPRR in the body fluid. By ELISA, serum levels of sPRR are increased during pregnancy77,78 and in patients with heart failure,79 gestational diabetes mellitus,80 obstructive sleep apnea syndrome,81 and primary epithelial ovarian cancer.82 In 374 patients with chronic kidney disease caused by hypertension and type 2 diabetes mellitus, serum sPRR is positively associated with serum creatinine, blood urea nitrogen, and proteinuria and inversely with estimated glomerular filtration rate.83 It is puzzling, however, that in this study serum sPRR levels were lower in patients with primary hypertension or diabetes mellitus than in those without these conditions.83 In 25 patients who underwent uninephrectomy, plasma sPRR further correlated with renal tubulointerstitial fibrosis.84 Despite the lack of correlation of plasma sPRR with circulating renin, prorenin, and aldosterone in healthy subjects,85 sPRR correlates positively with urinary angiotensinogen in patients with essential hypertension.86 Urinary angiotensinogen is widely considered as an index of intrarenal RAS87 despite some evidence for its hepatic origin.88 Overall, most of the previous studies favor plasma sPRR as a biomarker of certain diseases likely because of its association with the intrarenal RAS.A clue suggesting a biological function of renal PRR came from our immunostaining studies comparing antibodies against the different PRR domains. A commercial antibody against the C terminus of PRR (anti-PRR-C antibody)18,20 reproducibly labeled intercalated cells. However, to our surprise, an antibody against the N terminus of PRR (sPRR) only stained the apical membrane of principal cells. The anatomic evidence suggested an intriguing possibility that sPRR might be secreted from intercalated cells and secreted to the luminal side and then bind an as yet unknown protein on the apical membrane of principal cells, revealing a paracrine loop linking the 2 cell types in the CD; this paracrine mechanism may play a role in regulation of Na+ and water transport in the principal cells of the CD. To test this hypothesis, we generated a histidine-tagged recombinant sPRR, termed as sPRR-His, and examined its effect on AQP2 expression in primary IMCD cells. sPRR-His at the nanomolar range remarkably induced AQP2 mRNA and protein expression (Figure 4).89 The parallel increase in AQP2 promoter activity (Figure 4) suggested that the transcriptional mechanism may account for the upregulation of AQP2 expression by sPRR-His.89 We used STRING to predict proteins that interact with sPRR. This led to the discovery of frizzled-8 that interacted with sPRR to activate Wnt/β-catenin pathway and thus enhancement of AQP2 gene transcription.89 However, this mechanism does not seem to contribute to AQP2 redistribution after an acute AVP treatment.89 Because AVP stimulated sPRR release, we speculate that the sPRR/β-catenin/AQP2 pathway may primarily mediate the upregulation of AQP2 transcription during chronic AVP treatment. Although previous studies extensively focus on the detailed signaling mechanism of AQP2 trafficking between intracellular vesicles and apical plasma membrane, which occurs within minutes of AVP treatment,53,54,90,91 little is known about the mechanism of transcriptional regulation of AQP2 gene under chronic condition. Our results uncovered a novel role of sPRR in transcriptional regulation of AQP2 expression.Download figureDownload PowerPointFigure 4. Characterization of function of soluble form of (pro)renin receptor (sPRR). A recombinant PRR, termed sPRR-His (histidine-tagged recombinant sPRR), was expressed in a mammalian expressing system as a fusion protein that contained sPRR, a histidine tag in the C terminus, and a secretion signal peptide in the N terminus. A, sPRR-His was purified from the medium as a single 29.6 kDa band in 12% SDS PAGE. E1 to 4 denotes sequential fractions from the elution. B and C, Primary rat inner medullary collecting duct cells grown in Transwells were exposed to 10 nmol/L sPRR-His for 24 h, and aquaporin-2 (AQP2) expression was analyzed by qRT-quantitative real-time PCR and immunoblotting (n=5 per group). D, In a separate experiment, the cultured CD cells were transfected with an AQP2–luciferase construct and allowed to grow to confluence and then treated with vehicle or 10 nmol/L sPRR-His for 24 h, and the luciferase activity was assayed (n=5 per group). E, STRING is a template-based algorithm for protein–protein structure prediction. We used STRING to identify proteins that interact with sPRR. This analysis revealed 10 hits: CTSG (cathepsin G), ACE2 (angiotensin 1-converting enzyme 2), CMA1 (chymase 1), MME (membrane metalloendopeptidase), ACE (angiotensin 1-converting enzyme 1), CTSZ (cathepsin Z), ENPEP (glutamyl aminopeptidase), FZD8 (frizzled family receptor 8), WNT3A (wingless-type MMTV intergration 3A), and LRP6 (low-density lipoprotein receptor–related protein 6). Adapted from Lu et al.89 Copyright © 2016, National Academy of Sciences.The Wnt/β-catenin pathway is a multifunctional network critically involved in embryogenesis.92 Dephosphorylated β-catenin translocates to the nucleus where it recruits several transcription factors, such as lymphoid enhancer–binding factor 1/T cell–specific transcription factor.93 In low vertebrates including zebrafish and Xenopus, PRR functions as a key component of the membrane receptor complex in Wnt signaling to control embryogenesis.94 In addition, the Wnt/β-catenin pathway is also involved in physiological and pathophysiological processes. Aberrant activation of this pathway contributes to pathogenesis of chronic kidney disease.95–97 Our recent work demonstrates that the coupling of PRR with β-catenin signaling is operative in the setting of physiological regulation of water transport in the distal nephron.89 In support of this observation, Jung et al98 reported that tankyrase-mediated β-catenin pathway mediated AVP-induced AQP2 expression in mpkCCDc14 cells.The mechanism of how AVP regulates sPRR production, particularly the involvement of V1R versus V2R and intercalated cells versus principal cells, largely remains elusive. It has been shown that within the CD, V1R is mainly expressed in the intercalated cells regulating urine acidification.99 Given colocalization of V1R and PRR to the intercalated cells, it seems possible that V1R may mediate AVP-induced sPRR production. Another possibility also exists that V2R in principal cells may affect intercalated cell sPRR production through an intermediate mediator such as prostaglandins. Indeed, we found involvement of the prostaglandin EP4 receptor in mediating AVP-induced activation of PRR.56The in vitro capability of sPRR-His to regulate AQP2 expression as discussed above predicts an antidiuretic action of sPRR. This prediction has been confirmed by in vivo studies using 2 types of diabetes insipidus modes induced by inhibition of V2R and liver X receptor.89 Administration of sPRR-His via an intravenous route effectively attenuated polydipsia and polyuria and partially restored urine osmolality in both models.89 These results demonstrate therapeutic potential of sPRR-His for treatment of diabetes insipidus, particularly NDI. Central diabetes insipidus is caused by deficiency of AVP and thus can be treated with supplementing the missing hormone.100,101 NDI results from the insensitivity of the kidney to AVP usually because of genetic abnormalities with 90% of families having a mutation in V2R102,103 or with AQP2 mutations accounting for rest of the other families.104 Patients with NDI usually develop severe polyuria and polydipsia. It is particularly astonishing that children with congenital NDI can produce 20 L of urine daily and must drink a comparable amount of water to avoid dehydration.101 Infants with this disease may fail to thrive. To date, a specific therapy for
What problem does this paper attempt to address?
-
Nucleus of the Solitary Tract (pro)renin Receptor-Mediated Antihypertensive Effect Involves Nuclear Factor-Κb-cytokine Signaling in the Spontaneously Hypertensive Rat.
Jasenka Zubcevic,Joo Y. Jun,Gwyneth Lamont,Tatiane M. Murca,Peng Shi,Wei Yuan,Fan Lin,Jessica Marulanda Carvajal,Qiuhong Li,Colin Sumners,Mohan K. Raizada,Zhiying Shan
DOI: https://doi.org/10.1161/hypertensionaha.111.199836
IF: 9.8968
2013-01-01
Hypertension
Abstract:The importance of the (pro)renin receptor (PRR) in the function of the central nervous system is increasingly evident because PRR seems to play a role in neuronal control of cardiovascular function. PRR expression is elevated in the nucleus of the solitary tract (NTS) of spontaneously hypertensive rats (SHR). In this study, we tested the hypothesis that altered activity of PRR in the NTS is linked to hypertension. Eight weeks of chronic knockdown of the NTS PRR, using recombinant adeno-associated virus type 2 (AAV2)-PRR-small hairpain RNA (shRNA)–mediated gene transduction, caused a significant increase in mean arterial pressure (MAP) in the SHR (shRNA, 173±5; Control, 151±6 mm Hg) but not in Wistar Kyoto rats (shRNA, 108±7; Control, 106±6 mm Hg). The MAP elevation in the SHR was associated with decreased inflammatory markers tumor necrosis factor-α, interleukin-6, C-C motif ligand 5, and their transcription factor, nuclear factor-κB. Consistent with the pressor effects of the PRR knockdown, acute bilateral NTS injection of human renin (2 pmol/side) decreased MAP and heart rate (HR) in SHR (ΔMAP, −38±4 mm Hg; Δheart rate, −40±10 bpm), with negligible responses in Wistar Kyoto rats (ΔMAP, −4±3 mm Hg; Δheart rate, −12±7 bpm). These effects in SHR were attenuated (80%) by prorenin handle region peptide but were not affected by angiotensin II type 1 or angiotensin II type 2 receptor blockers. Finally, PRR activation in SHR neuronal cultures by prorenin activated nuclear factor-κB and increased mRNA levels of interleukin-1β (250-fold), tumor necrosis factor-α (32-fold), interleukin-6 (35-fold), C-C motif ligand 5 (12-fold), and interleukin-10 (7-fold) in a nuclear factor-κB–dependent but angiotensin II type 1 receptor–independent manner. Therefore, NTS PRR mediates antihypertensive effects via an angiotensin II–independent mechanism in SHR, which involves stimulation of the nuclear factor-κB–cytokine signaling pathway.
-
Involvement of the Brain (Pro) Renin Receptor in Cardiovascular Homeostasis
Zhiying Shan,Peng Shi,Adolfo E. Cuadra,Ying Dong,Fan Lin,Gwyneth J. Lamont,Michael J. Katovich,Colin Sumners,Mohan K. Raizada
DOI: https://doi.org/10.1161/CIRCRESAHA.110.226977
IF: 23.213
2010-01-01
Circulation Research
Abstract:Rationale: Despite overwhelming evidence of the importance of brain renin-angiotensin system (RAS), the very existence of intrinsic brain RAS remains controversial. Objective: To investigate the hypothesis that the brain (pro) renin receptor (PRR) is physiologically important in the brain RAS regulation and cardiovascular functions. Methods and Results: PRR is broadly distributed within neurons of cardiovascular-relevant brain regions. The physiological functions of PRR were studied in the supraoptic nucleus (SON) because this brain region showed greater levels of PRR mRNA in the spontaneously hypertensive rats (SHR) compared with normotensive Wistar-Kyoto (WKY) rats. Adeno-associated virus (AAV)-mediated overexpression of human PRR in the SON of normal rats resulted in increases in plasma and urine vasopressin, and decreases in H(2)O intake and urine output without any effects on mean arterial pressure and heart rate. Knockdown of endogenous PRR by AAV-short hairpin RNA in the SON of SHRs attenuated age-dependent increases in mean arterial pressure and caused a decrease in heart rate and plasma vasopressin. Incubation of neuronal cells in culture with human prorenin and angiotensinogen resulted in increased generation of angiotensin I and II. Furthermore, renin treatment increased phosphorylation of extracellular signal-regulated kinase 1/2 in neurons from both WKY rats and SHRs; however, the stimulation was 50% greater in the SHR. Conclusions: The study demonstrates that brain PRR is functional and plays a role in the neural control of cardiovascular functions. This may help resolve a long-held controversy concerning the existence of intrinsic and functional brain RAS. (Circ Res. 2010;107:934-938.)
-
Abstract 042: A Novel (pro)renin Receptor Variant Prr24 As A Specific Renin Receptor And Key Regulator Of Nkcc2 And Urine Concentrating Capability
Tianxin Yang,Yanting Chen,Ye Feng,Fei Wang,Huaqing Zheng,Ziwei Fu,Chang-Jiang Zou
DOI: https://doi.org/10.1161/hyp.79.suppl_1.042
IF: 9.8968
2022-09-01
Hypertension
Abstract:(Pro)renin receptor (PRR) has emerged as a key regulator of renal handling of Na + and water, and blood pressure (BP). Renal action of PRR is at least in part mediated through its ability to activate tissue prorenin and renin. In preliminary studies, investigation of a “non-specific” protein band recognized by an anti-PRR antibody against the extracellular domain led to identification of a novel 24-kDa isoform of PRR, termed as PRR24. PRR24 was encoded by a novel cDNA with part of 5’UTR arising from retention of intron 3 and an ATG in exon 5 as an alternative start codon so that this isoform overlaps completely with PRR except that N-terminal 136 amino acids are missing. PRR24 selectively bound and activated renin but not prorenin whereas PRR non-selectively interacted both prorenin and renin. PRR24 protein and mRNA expression was exclusively detected in the renal medulla but not renal cortex or extrarenal organs. Within the kidney, PRR24 mRNA was restricted to medullary thick ascending limb (mTAL) as assessed by RT-PCR on microdissected nephron segments. Using CRISP/Cas9 strategy, we generated a mouse model with mutagenesis of the start codon in exon 5 (termed PRR24 mut ) by replacing methionine with glutamine in PRR. Renal medullary protein expression of PRR24 was barely detectable contrasting unchanged PRR abundance in the null mice. PRR24 mut mice was born at Mendelian ratio and didn’t exhibit developmental abnormalities or mortality as seen in systemic PRR KO mice. PRR24 mut mice developed polyuria, hypoosmotic urine, polydipsia, hypotension (radiotelemetry MAP: WT 120 + 0.8 vs. Mutant 112 + 1.4 mmHg; p<0.05). Plasma volume assessed indirectly by hematocrit and directly assessed by using a fluorescent tracer was consistently reduced by 5-10%. Renal expression of NKCC2 was downregulated by 70% in parallel with reduced diuretic response to furosemide. Following 24-h water deprivation, the upregulation of NKCC2 expression was blunted in PRR24 mut mice associated with impaired urine concentrating capability as assessed by urine volume and osmolality. Overall, PRR24 is a novel PRR variant and serves as a specific renin receptor to regulate renal NKCC2 expression to ultimately determine urine concentrating capability.
peripheral vascular disease
-
(Pro)Renin receptor regulates potassium homeostasis through a local mechanism
Chuanming Xu,Aihua Lu,Hong Wang,Hui Fang,Li Zhou,Peng Sun,Tianxin Yang
DOI: https://doi.org/10.1152/ajprenal.00043.2016
2017-09-01
Abstract:(Pro)renin receptor (PRR) is highly expressed in the distal nephron, but it has an unclear functional implication. The present study was conducted to explore a potential role of renal PRR during high K+ (HK) loading. In normal Sprague-Dawley rats, a 1-wk HK intake increased renal expression of full-length PRR and urinary excretion of soluble PRR (sPRR). Administration of PRO20, a decoy peptide antagonist of PRR, in K+-loaded animals elevated plasma K+ level and decreased urinary K+ excretion, accompanied with suppressed urinary aldosterone excretion and intrarenal aldosterone levels. HK downregulated Na+-Cl- cotransporter (NCC) expression but upregulated CYP11B2 (cytochrome P-450, family 11, subfamily B, polypeptide 2), renal outer medullary K+ channel (ROMK), calcium-activated potassium channel subunit α1 (α-BK), α-Na+-K+-ATPase (α-NKA), and epithelial Na+ channel subunit β (β-ENaC), all of which were blunted by PRO20. After HK loading was completed, urinary, but not plasma renin, was upregulated, which was blunted by PRO20. The same experiments that were performed using adrenalectomized (ADX) rats yielded similar results. Interestingly, spironolactone treatment in HK-loaded ADX rats attenuated kaliuresis but promoted natriuresis, which was associated with the suppressed responses of β-ENaC, α-NKA, ROMK, and α-BK protein expression. Taken together, we discovered a novel role of renal PRR in regulation of K+ homeostasis through a local mechanism involving intrarenal renin-angiotensin-aldosterone system and coordinated regulation of membrane Na+- and K+-transporting proteins.
-
Abstract MP46: Mutagenesis Of PRR Cleavage Site In Mice Attenuates Angiotensin II-induced Hypertension And Suppresses Renin Expression
Fei Wang,Yanting Chen,Chang-jiang Zou,Renfei Luo,Tianxin Yang
DOI: https://doi.org/10.1161/hyp.78.suppl_1.mp46
IF: 9.8968
2021-09-01
Hypertension
Abstract:It is well demonstrated that activation of renal (pro)renin receptor (PRR) contributes to AngII-induced hypertension. Relatively, less is known about involvement of soluble PRR (sPRR), the extracellular domain of PRR, primarily generated by site-1 protease(S1P) and furin. Moreover, the relationship between PRR/sPRR and the renin-angiotensin system (RAS) has been debated. In the present study, we used CRISPR/Cas9 strategy to generate mice with mutagenesis of the overlapping cleavage site for both proteases in PRR (termed as PRR R279V/L282V ) to examine the phenotype during angiotensin II (AngII) infusion with particular emphasis on circulating and intrarenal renin status. PRR R279V/L282V mice exhibited a reduction of sPRR level in plasma by ~53% and in the kidney by ~82%, were fertile, and had no gross developmental abnormalities. At basal condition, PRR R279V/L282V mice had drastically suppressed renin levels from plasma (plasma total prorenin/renin content [ng/ml]: 9.3 ± 0.7 in PRR R279V/L282V mice vs. 12.8 ± 0.9 in WT mice, n = 5, p < 0.05), urine (urinary total prorenin/renin excretion [ng/24h]: 0.54 ± 0.11 in PRR R279V/L282V mice vs. 1.05 ± 0.15 in WT mice, n = 5, p < 0.05), and the kidney as compared to wild-type controls (WT). By telemetry, the hypertensive response of PRR R279V/L282V to AngII infusion (300 ng/min/kg) was blunted (MAP [mmHg] in Day 10: 125.9 ± 4.6 in PRR R279V/L282V mice vs. 138.5 ± 2.8 in WT mice, n = 8 for each group, p < 0.05) in parallel with attenuated response of intrarenal renin and renal medullary α-ENaC expression. We further examined the direct role of sPRR in renin regulation in As4.1 cells, a renin-expressing cell line isolated from mouse renal tumor and M-1 cells, a mouse cell line derived from the collecting duct. The exposure to sPRR-His in both cell types consistently elevated renin activity, and renin expression at both protein and mRNA levels, all of which were sensitive to inhibition by ICG-001, a β-catenin signaling inhibitor. Together, these results represent strong evidence favoring sPRR as a mediator of AngII-induced hypertension and a master regulator of renin expression at systemic and local levels. Therefore, PRR should be considered as an integrative member of the RAS.
peripheral vascular disease
-
Abstract P002: Soluble (pro)renin Receptor Contributes To Angiotensin II-Induced Hypertension In Mice
Ye Feng,Fei Wang,Kexin Peng,Yanting Chen,Renfei Luo,Chang-jiang Zou,Tianxin Yang
DOI: https://doi.org/10.1161/hyp.76.suppl_1.p002
IF: 9.8968
2020-09-01
Hypertension
Abstract:Activation of (pro)renin receptor (PRR) contributes to enhancement of intrarenal RAS and renal medullary α-ENaC and thus elevated blood pressure during angiotensin II (AngII) infusion. Soluble PRR (sPRR), the extracellular domain of PRR, is generated by multiple proteases including furin or ADAM19, and recently site-1 protease (S1P). The goal of the present study was to test the role of S1P-derived sPRR mediated AngII-induced hypertension. F1 B6129SF1/J mice were infused for 6 days with control (CTR) or AngII at 300 ng/kg/day alone or in combination with S1P inhibitor PF-429242 (PF) and blood pressure was monitored by radiotelemetry. S1P inhibition significantly attenuated AngII-induced hypertension accompanied with suppressed urinary and renal medullary renin levels and expression of renal medullary but not renal cortical α-ENaC expression. The effects of S1P inhibition were all reversed by supplement with histadine-tagged sPRR termed as sPRR-His. Mutagenesis of overlapping recognition site for S1P and furin in PRR for was generated in mice by CRISPR strategy (termed as mutant mice). Mutant mice were fertile and developed normally with a 50% reduction plasma sPRR. These mice exhibited blunted hypertensive response to AngII infusion accompanied with suppressed intrarenal renin levels. Ussing chamber technique was performed to determine amiloride-sensitive short-circuit current, an index of ENaC activity in confluent mpkCCD cells exposed for 24 h to AngII, AngII + PF, or AngII + PF + sPRR-His. AngII-induced ENaC activity was blocked by PF, which was reversed by sPRR-His. Together, these results support that sPRR derived from S1P or in combination with furin mediates AngII-induced hypertension through enhancement of intrarenal renin level and activation of ENaC.
peripheral vascular disease
-
Abstract 160: Angiotensin-(1-7) Decreases the Pro-inflammatory Effects of Prorenin in Hypothalamic Microglia
Meng Liu,Peng Shi,Colin Sumners
DOI: https://doi.org/10.1161/hyp.62.suppl_1.a160
IF: 9.8968
2013-01-01
Hypertension
Abstract:The chronic hypertensive action of angiotensin II (Ang II) mediated within central cardiovascular control centers includes a pro-inflammatory effect and induction of microglial activation in the paraventricular nucleus (PVN) of the hypothalamus. The objective here was to investigate whether angiotensin-(1-7), a protective arm of the renin-angiotensin system (RAS), can exert anti-inflammatory effects in hypothalamic microglia. The presence of Mas, the receptor for Ang-(1-7), within the PVN and other cardiovascular control centers of normotensive (SD; Sprague Dawley) rats was demonstrated by quantitative real time PCR analyses. Mas was maintained in microglial cultures prepared from the hypothalamus of SD rat pups based on immunostaining and PCR. Treatment of microglial cultures with Ang-(1-7) (100nM, 3 -12h) elicited time-dependent significant (P<0.05) decreases in the basal levels of mRNAs for the pro-inflammatory cytokines interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumor-necrosis factor α (TNFα), and in the microglial-macrophage marker CD11b. For example, the levels of IL-1β mRNA (normalized to GAPDH) within control and Ang-(1-7) treated cells were 1.0±0.09, 0.70±0.06, 0.40±0.04, and 0.48±0.07 (n=6). There was no significant effect of Ang-(1-7) on basal IL-1β mRNA at 10 nM (6h), and 1000 nM Ang-(1-7) produced no greater effect than 100 nM of this peptide. Treatment of cultures with the RAS component prorenin (PRO; 10, 20 or 50 nM; 6h) elicited highly significant (P<0.001) increases in IL-1β mRNA (4.2±0.10, 7.4±0.35, 16.7±0.46, respectively, n=6) when compared with controls (0.78±0.06), effects that far exceeded the ~2.0 fold increase in IL-1β mRNA elicited by Ang II (100 nM). Similar stimulatory effects of PRO on TNFα, IL-6 and CD11b mRNAs were also observed. The stimulatory action of PRO (10 nM) on IL-1β and TNFα mRNAs, but not CD11b mRNA, was attenuated by co-treatment with Ang-(1-7) (100 nM). For example, levels of IL-1β mRNA in PRO and Ang-(1-7)/PRO treated cells were 34.1±1.3 and 24.4±1.1 respectively (n=6), a reduction of ~29% (P<0.001). Collectively, these data suggest that Ang-(1-7) exerts a direct anti-inflammatory action at hypothalamic microglia, and inhibits PRO-induced pro-inflammatory effects.
-
Enzymatic sources and physio-pathological functions of soluble (pro)renin receptor
Qing Zhu,Tianxin Yang
DOI: https://doi.org/10.1097/MNH.0000000000000396
Abstract:Purpose of review: (Pro)renin receptor (PRR) belongs to type I transmembrane receptor family and binds both prorenin and renin, representing a potential regulator of the activity of the renin-angiotensin system. Soluble form of PRR (sPRR) is generated by intracellular protease-mediated cleavage of full-length PRR. The purpose of this review is to highlight recent advances in understanding the mechanisms of action and production of sPRR. Recent findings: It has recently been demonstrated that site-1-protease (S1P) plays a dominant role in the generation of sPRR. New evidence is also emerging to support a biological function of sPRR in the physiological regulation of fluid homeostasis as well as pathogenesis of chronic kidney disease. Summary: sPRR is a 28 kDa product of PRR cleavage via S1P-mediated protease activity. Not only does sPRR regulate renal tubular water transport, but it also mediates pathogenic responses to renal cellular injury. sPRR is likely involved in a wide range of physio-pathological processes.
-
Direct Pro-Inflammatory Effects of Prorenin on Microglia.
Peng Shi,Justin L Grobe,Fiona A Desland,Guannan Zhou,Xiao Z Shen,Zhiying Shan,Meng Liu,Mohan K Raizada,Colin Sumners
DOI: https://doi.org/10.1371/journal.pone.0092937
IF: 3.7
2014-01-01
PLoS ONE
Abstract:Neuroinflammation has been implicated in hypertension, and microglia have been proposed to play an important role in the progression of this disease. Here, we have studied whether microglia are activated within cardiovascular regulatory area(s) of the brain during hypertension, especially in high blood pressure that is associated with chronic activation of the renin-angiotensin-system. In addition, we determined whether prorenin, an essential component of the renin-angiotensin-system, exerts direct pro-inflammatory effects on these microglia. Our data indicate that two rodent models which display neurogenic hypertension and over activation of the renin-angiotensin-system in the brain (sRA mice and spontaneously hypertensive rats) exhibit microglial activation, and increased levels of pro-inflammatory cytokines, in the paraventricular nucleus of the hypothalamus, an area crucial for regulation of sympathetic outflow. Further, the renin-angiotensin-system component prorenin elicits direct activation of hypothalamic microglia in culture and induction of pro-inflammatory mechanisms in these cells, effects that involve prorenin receptor-induced NFκB activation. In addition, the prorenin-elicited increases in cytokine expression were fully abolished by microglial inhibitor minocycline, and were potentiated by pre-treatment of cells with angiotensin II. Taken together with our previous data which indicate that pro-inflammatory processes in the paraventricular nucleus are involved in the hypertensive action of renin-angiotensin-system, the novel discovery that prorenin exerts direct stimulatory effects on microglial activation and pro-inflammatory cytokine production provides support for the idea that renin-angiotensin-system -induced neurogenic hypertension is not restricted to actions of angiotensin II alone.
-
Binding of prorenin to (pro)renin receptor induces the proliferation of human umbilical artery smooth muscle cells via ROS generation and ERK1/2 activation.
Feng Y Liu,Xiao Y Liu,Li J Zhang,Yun P Cheng,Yi N Jiang
DOI: https://doi.org/10.1177/1470320314525215
2014-01-01
Journal of the Renin-Angiotensin-Aldosterone System
Abstract:Introduction: Since the discovery of the (pro) renin receptor (PRR), it has been considered as a novel bioactive molecule of the renin-angiotensin system (RAS). The activation of PRR can elicit a series of angiotensin II (AngII)-independent effects. Materials and methods: In this study, we investigated the effects of prorenin and PRR on the proliferation of human umbilical artery smooth muscle (HUASM) cells and explored the possible mechanisms underlying these effects. Results: The binding of prorenin to PRR can promote proliferation and upregulate the anti-apoptotic protein Bcl-2 and downregulate the pro-apoptotic protein Bax independently of AngII in HUASM cells. In addition, the binding of prorenin to PRR can also increase the production of reactive oxygen species (ROS) and the phosphorylation of extracellular signal-regulated kinase (ERK1/2) independently of AngII. The pretreatment of HUASM cells with an NADPH oxidase inhibitor DPI decreased the production of ROS and also decreased the phosphorylation of ERK1/2. Furthermore, pretreatment of HUASM cells with DPI and the ERK1/2 inhibitor PD98059 significantly attenuated the prorenin-induced proliferation and regulation of apoptosis factors. Conclusion: Binding of prorenin to PRR can induce HUASM cell proliferation via the ROS generation and ERK1/2 activation.
-
Abstract P030: Dct (pro)renin Receptor Via Its Soluble Product Inhibits Ncc Activity During Regulation Of Blood Pressure And Potassium Homeostasis In Mice
Chuanming Xu,Yanting Chen,Fei Wang,Shiying Xie,Changjiang Zou,Renfei Luo,Tianxin Yang
DOI: https://doi.org/10.1161/hyp.76.suppl_1.p030
IF: 9.8968
2020-09-01
Hypertension
Abstract:Sodium-chloride cotransporter (NCC), uniquely located at the distal convoluted tubule (DCT), is the target of thiazide diuretics and critically involved in renal handling of both Na + and K + . However, the mechanism of how NCC activity is regulated is incompletely understood. Here we report a novel role of (pro)renin receptor (PRR) and its cleavage product soluble PRR (sPRR) via site-1 protease (S1P) as negative regulators of NCC during high-salt or high-K + loading. Mice with DCT-specific deletion of PRR (termed as DCT PRR KO) was generated by crossing PRR floxed mice with a transgenic mouse line expressing Cre under the control of the parvalbumin (PV) promoter. Radiotelemrty demonstrated that under basic condition, DCT PRR KO mice exhibited modest hypertension (~5 mmHg) associated with reduced urinary Na + (Floxed: 0.20±0.02, KO: 0.12±0.01 mmol/24h, p<0.001), K + (Floxed: 0.29±0.02, KO: 0.18±0.03 mmol/24h, p<0.05), and Cl - (Floxed: 0.30±0.03, KO: 0.21±0.02 mmol/24h, p<0.01) excretion and increased in vivo NCC activity as assessed by hydrochlorothiazide (HCTN)-induced natriuresis ( by 61%). Renal protein abundance of pNCC-T53 (by 51%) but not total NCC was elevated in the null mice. Following a high salt diet, DCT PRR KO mice were salt sensitive as evidenced by a ~30 mm Hg increase of mean arterial pressure (MAP) which was sensitive to HCTN (ΔMAP, Floxed+HS: -2.05±1.50, KO+HS: -12.77±2.6 mmHg, p<0.05), contrasting to salt resistance in the floxed control. The null mice also exhibited impaired kaliuresis (Floxed+HK: 3.24±0.13, KO+HK: 2.32±0.23 mmol/24h, p<0.001) and hyperkalemia (Floxed+HK: 3.75±0.05, KO+HK: 4.40±0.08 mM, p<0.001) after high K + intake. This phenotype was recapitulated by treatment of C57/BL6 mice with S1P inhibitor PF429242. In cultured Flp-In T-REx 293 NCC cells, S1P-derived sPRR directly dephosphorylated NCC (by 40%) via activation of angiotensin II receptor type 1 (AT1R) independently of aldosterone. 1 / 2 Taken together, the present study has demonstrated that S1P-derived sPRR via AT1R negatively regulates NCC activity in the DCT to render salt resistance and to promote K + excretion. 2 / 2
peripheral vascular disease
-
Renal Rescue of Dopamine D2 Receptor Function Reverses Renal Injury and High Blood Pressure.
Prasad R. Konkalmatt,Laureano D. Asico,Yanrong Zhang,Yu Yang,Cinthia Drachenberg,Xiaoxu Zheng,Fei Han,Pedro A. Jose,Ines Armando
DOI: https://doi.org/10.1172/jci.insight.85888
IF: 9.4958
2016-01-01
JCI Insight
Abstract:Dopamine D2 receptor (DRD2) deficiency increases renal inflammation and blood pressure in mice. We show here that long-term renal-selective silencing of Drd2 using siRNA increases renal expression of proinflammatory and profibrotic factors and blood pressure in mice. To determine the effects of renal-selective rescue of Drd2 expression in mice, the renal expression of DRD2 was first silenced using siRNA and 14 days later rescued by retrograde renal infusion of adeno-associated virus (AAV) vector with DRD2. Renal Drd2 siRNA treatment decreased the renal expression of DRD2 protein by 55%, and DRD2 AAV treatment increased the renal expression of DRD2 protein by 7.5- to 10-fold. Renal-selective DRD2 rescue reduced the expression of proinflammatory factors and kidney injury, preserved renal function, and normalized systolic and diastolic blood pressure. These results demonstrate that the deleterious effects of renal-selective Drd2 silencing on renal function and blood pressure were rescued by renal-selective overexpression of DRD2. Moreover, the deleterious effects of 45-minute bilateral ischemia/reperfusion on renal function and blood pressure in mice were ameliorated by a renal-selective increase in DRD2 expression by the retrograde ureteral infusion of DRD2 AAV immediately after the induction of ischemia/reperfusion injury. Thus, 14 days after ischemia/reperfusion injury, the renal expression of profibrotic factors, serum creatinine, and blood pressure were lower in mice infused with DRD2 AAV than in those infused with control AAV. These results indicate an important role of renal DRD2 in limiting renal injury and preserving normal renal function and blood pressure.
-
Mutagenesis of the Cleavage Site of Pro Renin Receptor Abrogates Angiotensin II-Induced Hypertension in Mice
Fei Wang,Yanting Chen,Chang-Jiang Zou,Renfei Luo,Tianxin Yang
DOI: https://doi.org/10.1161/hypertensionaha.121.16770
IF: 9.8968
2021-05-25
Hypertension
Abstract:It is well demonstrated that activation of renal PRR ([pro]renin receptor) contributes to AngII (angiotensin II)-induced hypertension. Relatively, less is known for the function of sPRR (soluble PRR), the extracellular domain of PRR, primarily generated by S1P (site-1 protease) and furin. Moreover, the relationship between PRR/sPRR and the renin-angiotensin system (RAS) has been debated. In the present study, we used CRISPR/Cas9 strategy to generate mice with mutagenesis of the overlapping cleavage site for both proteases in PRR (termed as PRR R279V/L282V ) to examine the phenotype during AngII infusion with particular emphasis on circulating and intrarenal renin status. PRR R279V/L282V mice exhibited a reduction of sPRR level in plasma by ≈53% and in the kidney by ≈82%, were fertile, and had no gross developmental abnormalities. At basal condition, PRR R279V/L282V mice had drastically suppressed renin levels from plasma, urine, and the kidney as compared to wild-type controls. The hypertensive response of PRR R279V/L282V to AngII infusion was blunted in parallel with attenuated response of intrarenal renin and renal medullary α-epithelial sodium channel expression. By using Ussing chamber technique, primary collecting duct cells from PRR R279V/L282V mice exhibited blunted response of epithelial sodium channel activity to AngII as compared to wild-type cells. Together, these results represent strong evidence favoring sPRR as a mediator of AngII-induced hypertension and a master regulator of renin expression. Therefore, PRR should be considered as an integrative member of the RAS.
peripheral vascular disease
-
Abstract 063: Soluble (Pro)renin Receptor Acts Via Direct Activation Of Angiotensin Type 1 Receptor To Enhance Renal Aquaporin-2 Expression And Urine Concentrating Capability
Fei Wang,Jacob Lambert,Huaqing Zheng,Ziwei Fu,Chang-Jiang Zou,Tianxin Yang
DOI: https://doi.org/10.1161/hyp.79.suppl_1.063
IF: 9.8968
2022-09-01
Hypertension
Abstract:Abundant evidence has established an essential role of collecting duct (pro)renin receptor (PRR) in regulation of aquaporin-2 (AQP-2) expression and urine concentrating capability. Moreover, such AQP2-regulating and antidiuretic action of PRR is mediated by its cleavage product, the soluble PRR (sPRR). However, the mechanism of action of sPRR in this setting remains incompletely understood. In light of our recent report of direct interaction of sPRR and angiotensin type 1 receptor (AT1R) in the vascular endothelial cells, we examined the hypothesis that sPRR signals via AT1R in the kidney. In primary rat inner medullary collecting duct cells, exposure to a recombinant sPRR (termed as sPRR-His) at 10 nM for 24 h induced 4 fold increase in AQP2 protein abundance, which was blunted by `~50% by pretreatment with losartan. In C57/BL6 mice, administration of the V2R antagonist (OPC at 30 mg/kg/d via gavage for 3 days) resulted in symptoms of nephrogenic diabetes insipidus (NDI), including polydipsia, polyuria, and hypoosmotic urine, all of which were improved by subcutaneous infusion of sPRR-His at 30 μg/kg/d via minipump (urine volume [ml]: 5.3 ± 0.2 vs. 3.3 ± 0.3, n =5, p < 0.01; urine osmolality [Osm/kg. H2O]: 428.6 ± 29.2 vs. 704.6 ± 24.2, n =5, p < 0.01). Administration of losartan (5 mg/kg/d) almost completely reversed the therapeutic effect of sPRR-His (urine volume [ml]: 4.7 ± 0.2; urine osmolality [Osm/kg. H2O]: 486 ± 16.1). Immunoblotting demonstrated that sPRR-His treatment restored OPC-induced reduction of AQP2 protein abundance, which was reversed by losartan. Together, sPRR interacted with AT1R to control renal AQP2 expression and urine concentrating capability.
peripheral vascular disease
-
High potassium promotes mutual interaction between (pro)renin receptor and the local renin-angiotensin-aldosterone system in rat inner medullary collecting duct cells
Chuanming Xu,Hui Fang,Li Zhou,Aihua Lu,Tianxin Yang
DOI: https://doi.org/10.1152/ajpcell.00128.2016
2016-10-01
Abstract:(Pro)renin receptor (PRR) is predominantly expressed in the collecting duct (CD) with unclear functional implication. It is not known whether CD PRR is regulated by high potassium (HK). Here, we aimed to investigate the effect of HK on PRR expression and its role in regulation of aldosterone synthesis and release in the CD. In primary rat inner medullary CD cells, HK augmented PRR expression and soluble PPR (sPRR) release in a time- and dose-dependent manner, which was attenuated by PRR small interfering RNA (siRNA), eplerenone, and losartan. HK upregulated aldosterone release in parallel with an increase of CYP11B2 (cytochrome P-450, family 11, subfamily B, polypeptide 2) protein expression and upregulation of medium renin activity, both of which were attenuated by a PRR antagonist PRO20, PRR siRNA, eplerenone, and losartan. Similarly, prorenin upregulated aldosterone release and CYP11B2 expression, both of which were attenuated by PRR siRNA. Interestingly, a recombinant sPRR (sPRR-His) also stimulated aldosterone release and CYP11B2 expression. Taken together, we conclude that HK enhances a local renin-angiotensin-aldosterone system (RAAS), leading to increased PRR expression, which in turn amplifies the response of the RAAS, ultimately contributing to heightened aldosterone release.
-
Inhibition of (pro)renin Receptor Contributes to Renoprotective Effects of Angiotensin II Type 1 Receptor Blockade in Diabetic Nephropathy
Lin Zhang,Xiao-Fei An,Xin Ruan,Dong-Dong Huang,Li Zhou,Hong Xue,Li-Min Lu,Ming He
DOI: https://doi.org/10.3389/fphys.2017.00758
IF: 4
2017-01-01
Frontiers in Physiology
Abstract:Aims: Renal renin-angiotensin system (RAS) plays a pivotal role in the development of diabetic nephropathy (DN). Angiotensin II (Ang II) type 1 receptor (AT1R) blockade elevates (pro)renin, which may bind to (pro)renin receptor (PRR) and exert receptor-mediated, angiotensin-independent profibrotic effects. We therefore investigated whether PRR activation leads to the limited anti-fibrotic effects of AT1R blockade on DN, and whether PRR inhibition might ameliorate progression of DN. Methods: To address the issue, the expression of RAS components was tested in different stages of streptozotocin (STZ)-induced diabetic rats (6, 12, and 24 weeks) and 6-week AT1R blockade (losartan) treated diabetic rats. Using the blocker for PRR, the handle region peptide (HRP) of prorenin, the effects of PRR on high glucose or Ang II-induced proliferative and profibrotic actions were evaluated by measurement of cell proliferation, matrix metalloproteinase-2 (MMP-2) activity, activation of extracellular signal-regulated kinase 1/2 (ERK1/2) and transforming growth factor-β1 (TGF-β1) expression in rat mesangial cells (MCs). Results: PRR was downregulated in the kidneys of different stages of diabetic rats (6, 12, and 24 weeks). Moreover, 6-week losartan treatment further suppressed PRR expression via upregulating AT2R, and ameliorated diabetic renal injury. HRP inhibited high glucose and Ang II-induced proliferative and profibrotic effects in MCs through suppressing TGF-β1 expression and activating MMP-2. Meanwhile, HRP enhanced losartan's anti-fibrotic effects through further inhibiting phosphorylation of ERK1/2 and TGF-β1 expression. Moreover, the inhibitive effect of HRP on Ang II-induced TGF-β1 expression depended on the regulation of PRR expression by AT2R. Conclusions: Our findings suggest that inhibition of PRR contributes to renoprotection against diabetic nephropathy by AT1R blockade.
-
The activation of the(Pro)renin receptor (PRR) stimulates fibrotic factors expression independent of b‐catenin signaling pathway in collecting duct cells
Catherina Cuevas,Alexis Gonzalez,Nibaldo Inestrosa,Carlos Vio,Minolfa Prieto
DOI: https://doi.org/10.1096/fasebj.29.1_supplement.971.5
2015-04-01
The FASEB Journal
Abstract:Binding of the PRR to renin and prorenin activates intracellular signals independent of angiotensin II. The PRR is a component of the Wnt signaling pathway working as an adaptor between Wnt receptor and the vacuolar H + ‐ATPase. The expression of PRR is increased in the heart and kidney of hypertensive and diabetic animals; however its role in renal damage remains unclear. In this study we tested the hypothesis that the PRR activation induces the expression of fibronectin and collagen I via the b‐catenin pathway in mouse collecting duct M‐1 cells. Human recombinant prorenin ( hr PR) for 16 h in M‐1 cells increased the mRNA and protein levels of fibronectin (1.48±0.1 fold change), collagen I (1.53±0.1 fold‐change) as well as the b‐catenin target genes, cyclin D1 (1.9 ± 0.1 fold change) and c‐myc (2.1 ± 0.2 fold change). Inhibition of b‐catenin degradation with pyrvinium pamoate (10 ‐9 M) did not prevent the hr PR‐induced expression of all these genes. However, when the cells were transfected with a siRNA‐PRR, the hr PR‐dependent increases in fibronectin, collagen, cyclin D1 and c‐myc were prevented. Furthermore, hr PR treatment did not change the stationary protein level of β‐catenin or phosphorylation of GSK‐3β until 24h, but the level of pERK1/2 displayed a significant increase after 8h of treatment (2.9 ± 0.21 fold change, P <0.05).These results indicate that in collecting duct cells, PRR activation stimulates fibrotic genes independent of β‐catenin pathway.
cell biology,biochemistry & molecular biology,biology
-
Soluble (Pro)Renin Receptor as a Negative Regulator of NCC (Na+-Cl– Cotransporter) Activity
Chuanming Xu,Yanting Chen,Fei Wang,Shiying Xie,Tianxin Yang
DOI: https://doi.org/10.1161/hypertensionaha.121.16981
IF: 9.8968
2021-09-09
Hypertension
Abstract:Download figure Download PowerPoint NCC (Na + -Cl − cotransporter), uniquely located at the distal convoluted tubule (DCT), is the target of thiazide diuretics and critically involved in renal handling of both Na + and K + . However, the mechanism of how NCC activity is regulated remains incompletely understood. Here, we report a novel role of PRR ([pro]renin receptor) and its cleavage product sPRR (soluble PRR) via S1P (site-1 protease) as negative regulators of NCC during high-salt or high K + loading. Under basal condition, mice with DCT-specific deletion of PRR (DCT PRR KO) exhibited modest hypertension associated with reduced urinary Na + , K + , and Cl − excretion due to increased NCC activity. Following a high-salt diet, DCT PRR KO mice exhibited a ≈25 mm Hg increase of mean arterial pressure contrasting to salt resistance in the floxed controls. The null mice also exhibited impaired kaliuresis and hyperkalemia after high K + intake. This phenotype was recapitulated by treatment of C57/BL6 mice with S1P inhibitor PF429242. In cultured Flp-In T-REx 293 NCC cells, S1P-derived sPRR directly dephosphorylated NCC via activation of AT1R (angiotensin II receptor type 1). Taken together, the present study has demonstrated that S1P-derived sPRR via AT1R negatively regulates NCC activity in the DCT to render salt resistance and to promote K + excretion.
peripheral vascular disease
-
Collecting Duct Pro(Renin) Receptor Contributes to Unilateral Ureteral Obstruction–Induced Kidney Injury via Activation of the Intrarenal RAS
Renfei Luo,Kevin T. Yang,Fei Wang,Huaqing Zheng,Tianxin Yang
DOI: https://doi.org/10.1161/hypertensionaha.123.21740
IF: 9.8968
2024-08-24
Hypertension
Abstract:Hypertension, Ahead of Print. BACKGROUND:Although the concept of the intrarenal renin-angiotensin system (RAS) in renal disease is well-described in the literature, the precise pathogenic role and mechanism of this local system have not been directly assessed in the absence of confounding influence from the systemic RAS. The present study used novel mouse models of collecting duct (CD)–specific deletion of (pro)renin receptor (PRR) or renin together with pharmacological inhibition of soluble PRR production to unravel the precise contribution of the intrarenal RAS to renal injury induced by unilateral ureteral obstruction.METHODS:We examined the impact of CD-specific deletion of PRR, CD-specific deletion of renin, and S1P (site-1 protease) inhibitor PF429242 treatment on renal fibrosis and inflammation and the indices of the intrarenal RAS in a mouse model of unilateral ureteral obstruction.RESULTS:After 3 days of unilateral ureteral obstruction, the indices of the intrarenal RAS including the renal medullary renin content, activity and mRNA expression, and Ang (angiotensin) II content in obstructed kidneys of floxed mice were all increased. That effect was reversed with CD-specific deletion of PRR, CD-specific deletion of renin, and PF429242 treatment, accompanied by consistent improvement in renal fibrosis and inflammation. On the other hand, renal cortical renin levels were unaffected by unilateral ureteral obstruction, irrespective of the genotype. Similar results were obtained via pharmacological inhibition of S1P, the key protease for the generation of soluble PRR.CONCLUSIONS:Our results reveal that PRR-dependent/soluble PRR–dependent activation of CD renin represents a key determinant of the intrarenal RAS and, thus, obstruction-induced renal inflammation and fibrosis.
peripheral vascular disease
-
Site-1 Protease-Derived Soluble (Pro)Renin Receptor Contributes to Angiotensin II–Induced Hypertension in Mice
Ye Feng,Kexin Peng,Renfei Luo,Fei Wang,Tianxin Yang
DOI: https://doi.org/10.1161/hypertensionaha.120.15100
IF: 9.8968
2020-12-08
Hypertension
Abstract:Activation of PRR ([pro]renin receptor) contributes to enhancement of intrarenal RAS and renal medullary α-ENaC and thus elevated blood pressure during Ang II (angiotensin II) infusion. The goal of the present study was to test whether such action of PRR was mediated by sPRR (soluble PRR), generated by S1P (site-1 protease), a newly identified PRR cleavage protease. F1 B6129SF1/J mice were infused for 6 days with control or Ang II at 300 ng/kg per day alone or in combination with S1P inhibitor PF-429242 (PF), and blood pressure was monitored by radiotelemetry. S1P inhibition significantly attenuated Ang II–induced hypertension accompanied with suppressed urinary and renal medullary renin levels and expression of renal medullary but not renal cortical α-ENaC expression. The effects of S1P inhibition were all reversed by supplement with histidine-tagged sPRR termed as sPRR-His. Ussing chamber technique was performed to determine amiloride-sensitive short-circuit current, an index of ENaC activity in confluent mouse cortical collecting duct cell line cells exposed for 24 hours to Ang II, Ang II + PF, or Ang II + PF + sPRR-His. Ang II–induced ENaC activity was blocked by PF, which was reversed by sPRR-His. Together, these results support that S1P-derived sPRR mediates Ang II–induced hypertension through enhancement of intrarenal renin level and activation of ENaC.
peripheral vascular disease